Fri, Dec 26, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge funds bullish on palladium prices as shortage looms

Tuesday, August 06, 2013

amb
Palladium
Precy Dumlao, Opalesque Asia:

Hedge funds are bullish on palladium’s prices as global financial firms like Morgan Stanley and Credit Suisse have predicted there will be a shortage of the metal.

A report by BusinessWeek said that Morgan Stanley had predicted that global demand for palladium would exceed the 1.33 million ounces to be produced this year. For its part, Credit Suisse said the shortage for the metal would last up to 2016, while research firm CPM Group said the deficit would take a decade to fill.

John Stephenson, who manages C$2.65bn at First Asset Investment Management Inc in Toronto, was quoted as saying, "The supply situation is potentially very bullish for palladium, so I am probably the most bullish on palladium amongst all commodities. Any time supply and demand are out of whack, we see prices swing."

Palladium rose 3.3% to $728 in London this year, says BusinessWeek. Prices are expected to reach $800 an ounce in Q1 of 2014, a 9.2% increase from its current level and further rise to $850 in 2015. Already, speculators, including hedge funds, have raised their bets on higher prices as car sales are expected to to rise. 67% of the palladium supply is used in auto-catalysts.

Data from the U.S. Commodity Futures Trading Commission (CFTC) showed that hedge funds and other speculators hold a net 22,970 palladiu......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its